KaydedilenlerDerginizi ekleyin

Dergiler / Anatolian Current Medical Journal / 2022 / Cilt: 4 - Sayı: 3

Loss of smell in COVID-19 patients: is it related to clinical-radiological disease severity?

Hüsnü BAYKAL
Deniz ÇELİK
Sertan BULUT
Hasret Gizem KURT
Ayşe Füsun ÜLGER
Sayfa
228–233
Yayın Tarihi
2022-07-26
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It was determined that the patients with OD were mostly followed up on an outpatient basis, and they did not need hospitalization (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Olfactory dysfunction (OD) is one of the most prominent predictive symptoms in the early detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19), it may be the first symptom or accompany other symptoms.
📊
Temel Bulgular & Veri:The predictive value of OD is unknown in terms of the overall prognosis of COVID-19.
💡
Sonuç & Katkı:It was determined that the patients with OD were mostly followed up on an outpatient basis, and they did not need hospitalization (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:COVID-19 · Loss of Smell · Disease severity

Abstract

Objective: Olfactory dysfunction (OD) is one of the most prominent predictive symptoms in the early detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19), it may be the first symptom or accompany other symptoms. The predictive value of OD is unknown in terms of the overall prognosis of COVID-19. We aimed to investigate the relationship between OD and the clinical-radiological severity of the disease. Material and Method: Data of 208 COVID-19 patients (105 inpatients and 103 outpatients) who had positive Real-Time Polymerase Chain Reaction (PCR) tests between December 1, 2020, and January 15, 2021, were collected retrospectively. Presence of OD, symptoms on admission other than OD, days of hospital stay, peripheral blood analysis values, COVID-19 disease severity [World Health Organization (WHO) 2020 “Clinical management of COVID-19”] and radiologic classifications [Radiological Society of North America Expert Consensus Statement on Reporting (RSNA) Chest CT Findings Related to COVID-19] were retrospectively collected. Results: Analysis of 208 patients revealed that there were 105 (50.48%) inpatients and 103 (49.52%) outpatients. Among 102 patients who had OD, 68 were outpatients and 34 were inpatients. It was determined that the patients with OD were mostly followed up on an outpatient basis, and they did not need hospitalization (p

🔖

Bu Makaleye Atıf Yap

BAYKAL, H., ÇELİK, D., BULUT, S., KURT, H. G., ÜLGER, A. F. (2022). Loss of smell in COVID-19 patients: is it related to clinical-radiological disease severity?. Anatolian Current Medical Journal, Cilt: 4 - Sayı: 3, 228–233. https://ajindex.com/articles/733744

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 2015; 235: 277-87.
  2. Su S, Wong G, Shi W, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016; 24: 490-502.
  3. Yıldız M, Özturk Ergur F, Uzel Senel M, Özturk A. The use of prone positioning in severe COVID-19 outside the intensive care unit. Bratisl Lek Listy 2021; 122: 590-3.
  4. Bagheri SH, Asghari A, Farhadi M, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran 2020; 34: 62. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-90.
  5. Damm M, Temmel A, Welge-Lüssen A, et al. Epidemiologie und Therapie in Deutschland, Osterreich und der Schweiz [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland]. HNO 2004; 52: 112-20.
  6. German. Li X, Lui F. Anosmia. [Updated 2021 Sep 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https: //www.ncbi.nlm.nih.gov/books/NBK482152/ Suzuki M, Saito K, Min WP, et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 2007; 117: 272-7.
  7. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008; 82: 7264-75. Lefèvre N, Corazza F, Valsamis J, et al. The Number of X Chromosomes Influences Inflammatory Cytokine Production Following Toll-Like Receptor Stimulation. Front Immunol 2019; 10: 1052. Gandhi RT, Lynch JB, Del Rio C. Mild or moderate COVID-19. N Engl J Med 2020; 383: 1757-66.
  8. Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol 2020; 10: 821-31.
  9. Klopfenstein T, Kadiane-Oussou NJ, Toko L, et al. Features of anosmia in COVID-19. Med Mal Infect 2020; 50: 436-9.
  10. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020 Aug; 277: 2251-61.
  11. Meini S, Suardi LR, Busoni M, Roberts AT, Fortini A. Olfactory and gustatory dysfunctions in 1